Patel Dinesh V Ph D - 18 Oct 2023 Form 4 Insider Report for Protagonist Therapeutics, Inc (PTGX)

Role
President and CEO, Director
Signature
/s/ Matthew Gosling, Attorney-in-Fact for Dinesh V. Patel, Ph.D.
Issuer symbol
PTGX
Transactions as of
18 Oct 2023
Transactions value $
$25,260
Form type
4
Filing time
19 Oct 2023, 16:55:30 UTC
Previous filing
02 Jun 2023
Next filing
15 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTGX Common Stock Options Exercise $25.3K +6K +0.99% $4.21* 609K 18 Oct 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PTGX Stock Option (right to buy) Options Exercise $0 -6K -10% $0.00 54K 18 Oct 2023 Common Stock 6K $4.21 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes an aggregate of 401 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on September 9, 2023.
F2 These stock options are fully vested.